| Chronic Obstructive Pulmonary Disease |
1 |
1 |
| Lung |
0 |
0.49 |
| Interstitial Lung Disease |
0 |
0.47 |
| Asthma |
0 |
0.41 |
| Tuberculosis |
0 |
0.41 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.35 |
| Biologic Therapy |
0 |
0.35 |
| Inhaled Corticosteroid |
0 |
0.35 |
| Tumor Necrosis Factor-Alpha |
0 |
0.35 |
| Body Mass Index |
0 |
0.33 |
| Bronchiectasis |
0 |
0.33 |
| Corticosteroids |
0 |
0.33 |
| Tumor |
0 |
0.33 |
| Rheumatoid Arthritis |
0 |
0.29 |
| Quality of Life |
0 |
0.28 |
| Cardiovascular Risk Management |
0 |
0.2 |
| Pneumonia |
0 |
0.2 |
| Staphylococcal Infection |
0 |
0.2 |
| Arthritis |
0 |
0.16 |
| Cancer |
0 |
0.16 |
| Cardiovascular disease |
0 |
0.16 |
| Meta-Analysis |
0 |
0.16 |
| Pseudomonas Aeruginosa Infection |
0 |
0.16 |
| Renal Disease |
0 |
0.16 |
| Staphylococcus Aureus Infection |
0 |
0.16 |
| Thorax |
0 |
0.16 |